CQ Press home pageYour ProfileE-mail AlertFavorite DocumentsSaved SearchesDocument History

Advanced SearchBrowse Articles by TopicBrowse Articles by DateFloor Vote SearchBrowse Votes by TopicBrowse Votes by DateCQ Press Electronic Library home page
HomeAboutFrequently Asked QuestionsLogout
CQ Magazine home page

Browse Votes by Date

 2024
 September

Abelson Nomination -- Cloture (9/9/2024)
Counter CCP Malign Influence Fund -- Passage (9/9/2024)
Prohibit Federal Agency Biotech Procurement from Foreign Adversaries -- Passage (9/9/2024)
Abelson Nomination -- Confirmation (9/10/2024)
Counter-China Programs; Fiscal 2025 Continuing Appropriations -- Previous Question (9/10/2024)
Counter-China Programs; Fiscal 2025 Continuing Appropriations -- Rule (9/10/2024)
DHS Restrictions on Confucius Institutes -- DHS Confucius Institutes Report (9/10/2024)
DHS Restrictions on Confucius Institutes -- Passage (9/10/2024)
DHS Restrictions on Confucius Institutes -- Recommit (9/10/2024)
Hong Kong Economic and Trade Office Certification -- Passage (9/10/2024)
Vargas Nomination -- Cloture (9/10/2024)
Vargas Nomination -- Confirmation (9/10/2024)
Counter CCP Threats Initiative -- Passage (9/11/2024)
Counter CCP Threats Initiative -- Recommit (9/11/2024)
Lanthier Nomination -- Cloture (9/11/2024)
Lanthier Nomination -- Confirmation (9/11/2024)
Provinzino Nomination -- Cloture (9/11/2024)
Reviews of Foreign Agriculture Investments -- Passage (9/11/2024)
Reviews of Foreign Agriculture Investments -- Recommit (9/11/2024)
Senate Approval of WHO Treaties -- Recommit (9/11/2024)
Senate Approval of WHO Treaties -- Support Taiwan Participation in WHO (9/11/2024)
Senate Approval of WHO Treaty -- Passage (9/11/2024)
No Credits for EVs Made with Certain Foreign Parts -- Passage (9/12/2024)
No Credits for EVs Made with Certain Foreign Parts -- Recommit (9/12/2024)
Provinzino Nomination -- Confirmation (9/12/2024)
Ritz Nomination -- Cloture (9/12/2024)
Ritz Nomination -- Confirmation (9/16/2024)
Billie Jean King Congressional Gold Medal Award -- Passage (9/17/2024)
Costello Nomination -- Cloture (9/17/2024)
Costello Nomination -- Confirmation (9/17/2024)
IVF Act -- Cloture (9/17/2024)
Tax Penalties on Foreign-Tied Political Donors -- Passage (9/17/2024)
Anti-'Woke' Policies; Israel and Palestine Product Labeling; Disapprove EPA Pollutant Rule; Prohibit Funds for 'Sanctuary Cities'; Inadmissibility and Removal for Domestic Violence -- Previous Question (9/18/2024)
Anti-'Woke' Policies; Israel and Palestine Product Labeling; Disapprove EPA Pollutant Rule; Prohibit Funds for 'Sanctuary Cities'; Inadmissibility and Removal for Domestic Violence -- Rule (9/18/2024)
Autism CARES Programs Reauthorization -- Passage (9/18/2024)
Child Welfare Services Reauthorization -- Passage (9/18/2024)
Court Nomination -- Cloture (9/18/2024)
Court Nomination -- Confirmation (9/18/2024)
Establish FCC 6G Taskforce -- Passage (9/18/2024)
Fiscal 2025 Continuing Appropriations -- Passage (9/18/2024)
Fiscal 2025 Continuing Appropriations -- Recommit (9/18/2024)
Inadmissibility and Removal of Foreign Nationals for Domestic Violence -- Passage (9/18/2024)
Israel and Palestine Product Labeling Rules -- Passage (9/18/2024)
Prohibit ESG Investments in Retirement Plans -- Passage (9/18/2024)
Prohibit ESG Investments in Retirement Plans -- Recommit (9/18/2024)
Protocols for Locating Missing Children -- Passage (9/18/2024)
Taylor Nomination -- Confirmation (9/18/2024)
Jenkins Nomination -- Cloture (9/19/2024)
Limiting Environmental, Social and Governance Considerations -- Passage (9/19/2024)
Limiting Environmental, Social and Governance Considerations -- Recommit (9/19/2024)
Prohibiting DEI and Requiring Free Speech in Higher Education -- Passage (9/19/2024)
Prohibiting DEI and Requiring Free Speech in Higher Education -- Recommit (9/19/2024)
Veterans Benefits Funding -- Department of Energy Offset (9/19/2024)
Disapprove EPA Emissions Rule -- Passage (9/20/2024)
Expanded Secret Service Protection for Presidential Candidates -- Passage (9/20/2024)
Prohibit Funds for 'Sanctuary Cities' -- Passage (9/20/2024)
Prohibit Funds for 'Sanctuary Cities' -- Recommit (9/20/2024)
Commission on International Religious Freedom Reauthorization -- Passage (9/23/2024)
Excempt Certain Semiconductor Projects from NEPA Reviews -- Passage (9/23/2024)
Fiscal 2025 NASA Reauthorization -- Passage (9/23/2024)
Jenkins Nomination -- Confirmation (9/23/2024)
CCP Sanctions; Condemn Afghanistan Withdrawal; Bail Bond Insurance Fraud; Wildfire Programs -- Previous Question (9/24/2024)
CCP Sanctions; Condemn Afghanistan Withdrawal; Bail Bond Insurance Fraud; Wildfire Programs -- Rule (9/24/2024)
Emergency Authorities in Wildfire Areas -- Passage (9/24/2024)
Establish DHS Cybersecurity Training Program -- Passage (9/24/2024)
Establish Energy Department Pipeline Demonstration Initiative -- Passage (9/24/2024)
Little Saigon Vietnam War Veterans Memorial Post Office -- Passage (9/24/2024)
Sfraga Nomination -- Cloture (9/24/2024)
Sfraga Nomination -- Confirmation (9/24/2024)
Bail Bond Insurance Regulations -- Passage (9/25/2024)
Bail Bond Insurance Regulations -- Recommit (9/25/2024)
CCP Assets and Visa Sanctions -- Passage (9/25/2024)
CCP Assets and Visa Sanctions -- Sanction CCP Entities Tied to Fentanyl Production (9/25/2024)
Condemn Afghanistan Withdrawal -- Adoption (9/25/2024)
Congressional Observer Access Permissions -- Motion to Concur (9/25/2024)
Continuing Appropriations -- Passage (9/25/2024)
Conway Nomination -- Cloture (9/25/2024)
Conway Nomination -- Confirmation (9/25/2024)
Fiscal 2025 Budget Resolution -- Motion to Proceed (9/25/2024)
Fiscal 2025 Short-Term Appropriations -- Passage (9/25/2024)

©2026, CQ Press, an Imprint of SAGE Publishing. CQ Magazine is a registered trademark
of CQ-Roll Call, Inc. All copyright rights in CQ Magazine are the property of CQ-Roll Call, Inc.
CQ Press is a registered trademark of Congressional Quarterly Inc. All Rights Reserved.
2455 Teller Road • Thousand Oaks, CA 91320 • 1-800-818-7243
Privacy Policy | CCPA – Do Not Sell My Personal Information | CCPA | Manage Cookies
Masthead | Terms & Conditions | Contact